Global Molecular Diagnostics in Point of Care Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics in Point of Care Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Polymerase Chain Reaction
1.2.3 In Situ Hybridization
1.2.4 Gene Chips
1.2.5 Next Generation Sequencing
1.3 Market by Application
1.3.1 Global Molecular Diagnostics in Point of Care Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Independent Clinical Laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics in Point of Care Market Perspective (2020-2031)
2.2 Global Molecular Diagnostics in Point of Care Growth Trends by Region
2.2.1 Global Molecular Diagnostics in Point of Care Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Molecular Diagnostics in Point of Care Historic Market Size by Region (2020-2025)
2.2.3 Molecular Diagnostics in Point of Care Forecasted Market Size by Region (2026-2031)
2.3 Molecular Diagnostics in Point of Care Market Dynamics
2.3.1 Molecular Diagnostics in Point of Care Industry Trends
2.3.2 Molecular Diagnostics in Point of Care Market Drivers
2.3.3 Molecular Diagnostics in Point of Care Market Challenges
2.3.4 Molecular Diagnostics in Point of Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics in Point of Care Players by Revenue
3.1.1 Global Top Molecular Diagnostics in Point of Care Players by Revenue (2020-2025)
3.1.2 Global Molecular Diagnostics in Point of Care Revenue Market Share by Players (2020-2025)
3.2 Global Molecular Diagnostics in Point of Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Molecular Diagnostics in Point of Care Revenue
3.4 Global Molecular Diagnostics in Point of Care Market Concentration Ratio
3.4.1 Global Molecular Diagnostics in Point of Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Point of Care Revenue in 2024
3.5 Global Key Players of Molecular Diagnostics in Point of Care Head office and Area Served
3.6 Global Key Players of Molecular Diagnostics in Point of Care, Product and Application
3.7 Global Key Players of Molecular Diagnostics in Point of Care, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics in Point of Care Breakdown Data by Type
4.1 Global Molecular Diagnostics in Point of Care Historic Market Size by Type (2020-2025)
4.2 Global Molecular Diagnostics in Point of Care Forecasted Market Size by Type (2026-2031)
5 Molecular Diagnostics in Point of Care Breakdown Data by Application
5.1 Global Molecular Diagnostics in Point of Care Historic Market Size by Application (2020-2025)
5.2 Global Molecular Diagnostics in Point of Care Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Molecular Diagnostics in Point of Care Market Size (2020-2031)
6.2 North America Molecular Diagnostics in Point of Care Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Molecular Diagnostics in Point of Care Market Size by Country (2020-2025)
6.4 North America Molecular Diagnostics in Point of Care Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Molecular Diagnostics in Point of Care Market Size (2020-2031)
7.2 Europe Molecular Diagnostics in Point of Care Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Molecular Diagnostics in Point of Care Market Size by Country (2020-2025)
7.4 Europe Molecular Diagnostics in Point of Care Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics in Point of Care Market Size (2020-2031)
8.2 Asia-Pacific Molecular Diagnostics in Point of Care Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2020-2025)
8.4 Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics in Point of Care Market Size (2020-2031)
9.2 Latin America Molecular Diagnostics in Point of Care Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Molecular Diagnostics in Point of Care Market Size by Country (2020-2025)
9.4 Latin America Molecular Diagnostics in Point of Care Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics in Point of Care Market Size (2020-2031)
10.2 Middle East & Africa Molecular Diagnostics in Point of Care Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2020-2025)
10.4 Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Molecular Diagnostics in Point of Care Introduction
11.1.4 Abbott Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Accelerate Diagnostics
11.2.1 Accelerate Diagnostics Company Details
11.2.2 Accelerate Diagnostics Business Overview
11.2.3 Accelerate Diagnostics Molecular Diagnostics in Point of Care Introduction
11.2.4 Accelerate Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.2.5 Accelerate Diagnostics Recent Development
11.3 Ador Diagnostics
11.3.1 Ador Diagnostics Company Details
11.3.2 Ador Diagnostics Business Overview
11.3.3 Ador Diagnostics Molecular Diagnostics in Point of Care Introduction
11.3.4 Ador Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.3.5 Ador Diagnostics Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Molecular Diagnostics in Point of Care Introduction
11.4.4 Beckman Coulter Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.4.5 Beckman Coulter Recent Development
11.5 Becton, Dickinson and Company
11.5.1 Becton, Dickinson and Company Company Details
11.5.2 Becton, Dickinson and Company Business Overview
11.5.3 Becton, Dickinson and Company Molecular Diagnostics in Point of Care Introduction
11.5.4 Becton, Dickinson and Company Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.5.5 Becton, Dickinson and Company Recent Development
11.6 Binx Health
11.6.1 Binx Health Company Details
11.6.2 Binx Health Business Overview
11.6.3 Binx Health Molecular Diagnostics in Point of Care Introduction
11.6.4 Binx Health Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.6.5 Binx Health Recent Development
11.7 Biocartis
11.7.1 Biocartis Company Details
11.7.2 Biocartis Business Overview
11.7.3 Biocartis Molecular Diagnostics in Point of Care Introduction
11.7.4 Biocartis Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.7.5 Biocartis Recent Development
11.8 bioMérieux
11.8.1 bioMérieux Company Details
11.8.2 bioMérieux Business Overview
11.8.3 bioMérieux Molecular Diagnostics in Point of Care Introduction
11.8.4 bioMérieux Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.8.5 bioMérieux Recent Development
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Molecular Diagnostics in Point of Care Introduction
11.9.4 Bio-Rad Laboratories Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.9.5 Bio-Rad Laboratories Recent Development
11.10 Bosch Healthcare Solutions
11.10.1 Bosch Healthcare Solutions Company Details
11.10.2 Bosch Healthcare Solutions Business Overview
11.10.3 Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Introduction
11.10.4 Bosch Healthcare Solutions Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.10.5 Bosch Healthcare Solutions Recent Development
11.11 Curetis
11.11.1 Curetis Company Details
11.11.2 Curetis Business Overview
11.11.3 Curetis Molecular Diagnostics in Point of Care Introduction
11.11.4 Curetis Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.11.5 Curetis Recent Development
11.12 Eurofins Scientific
11.12.1 Eurofins Scientific Company Details
11.12.2 Eurofins Scientific Business Overview
11.12.3 Eurofins Scientific Molecular Diagnostics in Point of Care Introduction
11.12.4 Eurofins Scientific Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.12.5 Eurofins Scientific Recent Development
11.13 Genetic Signatures
11.13.1 Genetic Signatures Company Details
11.13.2 Genetic Signatures Business Overview
11.13.3 Genetic Signatures Molecular Diagnostics in Point of Care Introduction
11.13.4 Genetic Signatures Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.13.5 Genetic Signatures Recent Development
11.14 Grifols
11.14.1 Grifols Company Details
11.14.2 Grifols Business Overview
11.14.3 Grifols Molecular Diagnostics in Point of Care Introduction
11.14.4 Grifols Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.14.5 Grifols Recent Development
11.15 Hibergene Diagnostics
11.15.1 Hibergene Diagnostics Company Details
11.15.2 Hibergene Diagnostics Business Overview
11.15.3 Hibergene Diagnostics Molecular Diagnostics in Point of Care Introduction
11.15.4 Hibergene Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.15.5 Hibergene Diagnostics Recent Development
11.16 Lumos Diagnostics
11.16.1 Lumos Diagnostics Company Details
11.16.2 Lumos Diagnostics Business Overview
11.16.3 Lumos Diagnostics Molecular Diagnostics in Point of Care Introduction
11.16.4 Lumos Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.16.5 Lumos Diagnostics Recent Development
11.17 Roche
11.17.1 Roche Company Details
11.17.2 Roche Business Overview
11.17.3 Roche Molecular Diagnostics in Point of Care Introduction
11.17.4 Roche Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.17.5 Roche Recent Development
11.18 Siemens
11.18.1 Siemens Company Details
11.18.2 Siemens Business Overview
11.18.3 Siemens Molecular Diagnostics in Point of Care Introduction
11.18.4 Siemens Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.18.5 Siemens Recent Development
11.19 Thermo Fisher Scientific
11.19.1 Thermo Fisher Scientific Company Details
11.19.2 Thermo Fisher Scientific Business Overview
11.19.3 Thermo Fisher Scientific Molecular Diagnostics in Point of Care Introduction
11.19.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Point of Care Business (2020-2025)
11.19.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Molecular Diagnostics in Point of Care Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of In Situ Hybridization
Table 4. Key Players of Gene Chips
Table 5. Key Players of Next Generation Sequencing
Table 6. Global Molecular Diagnostics in Point of Care Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Molecular Diagnostics in Point of Care Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Molecular Diagnostics in Point of Care Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Molecular Diagnostics in Point of Care Market Share by Region (2020-2025)
Table 10. Global Molecular Diagnostics in Point of Care Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Molecular Diagnostics in Point of Care Market Share by Region (2026-2031)
Table 12. Molecular Diagnostics in Point of Care Market Trends
Table 13. Molecular Diagnostics in Point of Care Market Drivers
Table 14. Molecular Diagnostics in Point of Care Market Challenges
Table 15. Molecular Diagnostics in Point of Care Market Restraints
Table 16. Global Molecular Diagnostics in Point of Care Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Molecular Diagnostics in Point of Care Market Share by Players (2020-2025)
Table 18. Global Top Molecular Diagnostics in Point of Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Point of Care as of 2024)
Table 19. Ranking of Global Top Molecular Diagnostics in Point of Care Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Molecular Diagnostics in Point of Care Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Molecular Diagnostics in Point of Care, Headquarters and Area Served
Table 22. Global Key Players of Molecular Diagnostics in Point of Care, Product and Application
Table 23. Global Key Players of Molecular Diagnostics in Point of Care, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnostics in Point of Care Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Molecular Diagnostics in Point of Care Revenue Market Share by Type (2020-2025)
Table 27. Global Molecular Diagnostics in Point of Care Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Molecular Diagnostics in Point of Care Revenue Market Share by Type (2026-2031)
Table 29. Global Molecular Diagnostics in Point of Care Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Molecular Diagnostics in Point of Care Revenue Market Share by Application (2020-2025)
Table 31. Global Molecular Diagnostics in Point of Care Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Molecular Diagnostics in Point of Care Revenue Market Share by Application (2026-2031)
Table 33. North America Molecular Diagnostics in Point of Care Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Molecular Diagnostics in Point of Care Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Molecular Diagnostics in Point of Care Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Molecular Diagnostics in Point of Care Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Molecular Diagnostics in Point of Care Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Molecular Diagnostics in Point of Care Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Molecular Diagnostics in Point of Care Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Molecular Diagnostics in Point of Care Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Molecular Diagnostics in Point of Care Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Molecular Diagnostics in Point of Care Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Molecular Diagnostics in Point of Care Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2026-2031) & (US$ Million)
Table 48. Abbott Company Details
Table 49. Abbott Business Overview
Table 50. Abbott Molecular Diagnostics in Point of Care Product
Table 51. Abbott Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Accelerate Diagnostics Company Details
Table 54. Accelerate Diagnostics Business Overview
Table 55. Accelerate Diagnostics Molecular Diagnostics in Point of Care Product
Table 56. Accelerate Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 57. Accelerate Diagnostics Recent Development
Table 58. Ador Diagnostics Company Details
Table 59. Ador Diagnostics Business Overview
Table 60. Ador Diagnostics Molecular Diagnostics in Point of Care Product
Table 61. Ador Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 62. Ador Diagnostics Recent Development
Table 63. Beckman Coulter Company Details
Table 64. Beckman Coulter Business Overview
Table 65. Beckman Coulter Molecular Diagnostics in Point of Care Product
Table 66. Beckman Coulter Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 67. Beckman Coulter Recent Development
Table 68. Becton, Dickinson and Company Company Details
Table 69. Becton, Dickinson and Company Business Overview
Table 70. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Product
Table 71. Becton, Dickinson and Company Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 72. Becton, Dickinson and Company Recent Development
Table 73. Binx Health Company Details
Table 74. Binx Health Business Overview
Table 75. Binx Health Molecular Diagnostics in Point of Care Product
Table 76. Binx Health Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 77. Binx Health Recent Development
Table 78. Biocartis Company Details
Table 79. Biocartis Business Overview
Table 80. Biocartis Molecular Diagnostics in Point of Care Product
Table 81. Biocartis Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 82. Biocartis Recent Development
Table 83. bioMérieux Company Details
Table 84. bioMérieux Business Overview
Table 85. bioMérieux Molecular Diagnostics in Point of Care Product
Table 86. bioMérieux Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 87. bioMérieux Recent Development
Table 88. Bio-Rad Laboratories Company Details
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Product
Table 91. Bio-Rad Laboratories Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Development
Table 93. Bosch Healthcare Solutions Company Details
Table 94. Bosch Healthcare Solutions Business Overview
Table 95. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Product
Table 96. Bosch Healthcare Solutions Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 97. Bosch Healthcare Solutions Recent Development
Table 98. Curetis Company Details
Table 99. Curetis Business Overview
Table 100. Curetis Molecular Diagnostics in Point of Care Product
Table 101. Curetis Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 102. Curetis Recent Development
Table 103. Eurofins Scientific Company Details
Table 104. Eurofins Scientific Business Overview
Table 105. Eurofins Scientific Molecular Diagnostics in Point of Care Product
Table 106. Eurofins Scientific Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 107. Eurofins Scientific Recent Development
Table 108. Genetic Signatures Company Details
Table 109. Genetic Signatures Business Overview
Table 110. Genetic Signatures Molecular Diagnostics in Point of Care Product
Table 111. Genetic Signatures Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 112. Genetic Signatures Recent Development
Table 113. Grifols Company Details
Table 114. Grifols Business Overview
Table 115. Grifols Molecular Diagnostics in Point of Care Product
Table 116. Grifols Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 117. Grifols Recent Development
Table 118. Hibergene Diagnostics Company Details
Table 119. Hibergene Diagnostics Business Overview
Table 120. Hibergene Diagnostics Molecular Diagnostics in Point of Care Product
Table 121. Hibergene Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 122. Hibergene Diagnostics Recent Development
Table 123. Lumos Diagnostics Company Details
Table 124. Lumos Diagnostics Business Overview
Table 125. Lumos Diagnostics Molecular Diagnostics in Point of Care Product
Table 126. Lumos Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 127. Lumos Diagnostics Recent Development
Table 128. Roche Company Details
Table 129. Roche Business Overview
Table 130. Roche Molecular Diagnostics in Point of Care Product
Table 131. Roche Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 132. Roche Recent Development
Table 133. Siemens Company Details
Table 134. Siemens Business Overview
Table 135. Siemens Molecular Diagnostics in Point of Care Product
Table 136. Siemens Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 137. Siemens Recent Development
Table 138. Thermo Fisher Scientific Company Details
Table 139. Thermo Fisher Scientific Business Overview
Table 140. Thermo Fisher Scientific Molecular Diagnostics in Point of Care Product
Table 141. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Point of Care Business (2020-2025) & (US$ Million)
Table 142. Thermo Fisher Scientific Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report


List of Figures
Figure 1. Molecular Diagnostics in Point of Care Picture
Figure 2. Global Molecular Diagnostics in Point of Care Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Molecular Diagnostics in Point of Care Market Share by Type: 2024 VS 2031
Figure 4. Polymerase Chain Reaction Features
Figure 5. In Situ Hybridization Features
Figure 6. Gene Chips Features
Figure 7. Next Generation Sequencing Features
Figure 8. Global Molecular Diagnostics in Point of Care Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Molecular Diagnostics in Point of Care Market Share by Application: 2024 VS 2031
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Independent Clinical Laboratories Case Studies
Figure 12. Molecular Diagnostics in Point of Care Report Years Considered
Figure 13. Global Molecular Diagnostics in Point of Care Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Molecular Diagnostics in Point of Care Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Molecular Diagnostics in Point of Care Market Share by Region: 2024 VS 2031
Figure 16. Global Molecular Diagnostics in Point of Care Market Share by Players in 2024
Figure 17. Global Top Molecular Diagnostics in Point of Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Point of Care as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Point of Care Revenue in 2024
Figure 19. North America Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Molecular Diagnostics in Point of Care Market Share by Country (2020-2031)
Figure 21. United States Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Molecular Diagnostics in Point of Care Market Share by Country (2020-2031)
Figure 25. Germany Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Molecular Diagnostics in Point of Care Market Share by Region (2020-2031)
Figure 33. China Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Molecular Diagnostics in Point of Care Market Share by Country (2020-2031)
Figure 41. Mexico Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Molecular Diagnostics in Point of Care Market Share by Country (2020-2031)
Figure 45. Turkey Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Molecular Diagnostics in Point of Care Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Abbott Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 49. Accelerate Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 50. Ador Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 51. Beckman Coulter Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 52. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 53. Binx Health Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 54. Biocartis Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 55. bioMérieux Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 56. Bio-Rad Laboratories Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 57. Bosch Healthcare Solutions Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 58. Curetis Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 59. Eurofins Scientific Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 60. Genetic Signatures Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 61. Grifols Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 62. Hibergene Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 63. Lumos Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 64. Roche Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 65. Siemens Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2020-2025)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit